Literature DB >> 17140062

[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].

Gary R Lichtenstein1, Maria T Sbreu, Russell Cohen, William Tremaine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140062

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


× No keyword cloud information.
  5 in total

1.  The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Authors:  Hiromistu Ban; Akira Andoh; Hirotsugu Imaeda; Ayako Kobori; Shigeki Bamba; Tomoyuki Tsujikawa; Masaya Sasaki; Yasuharu Saito; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2010-10       Impact factor: 7.527

2.  Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Authors:  Rie Osaki; Hirotsugu Imaeda; Hiromitsu Ban; Tomoki Aomatsu; Shigeki Bamba; Tomoyuki Tsujikawa; Masaya Sasaki; Yoshihide Fujiyama; Akira Andoh
Journal:  Exp Ther Med       Date:  2011-06-16       Impact factor: 2.447

3.  Immunomodulators and immunosuppressants for Japanese patients with ulcerative colitis.

Authors:  Shigeki Bamba; Tomoyuki Tsujikawa; Masaya Sasaki; Yoshihide Fujiyama; Akira Andoh
Journal:  ISRN Gastroenterol       Date:  2011-05-25

4.  Tacrolimus for Remission Induction and Maintenance Therapy in Patients with Ulcerative Colitis: A Retrospective Evaluation Study.

Authors:  Ayumi Ito; Bunei Iizuka; Teppei Omori; Shinichi Nakamura; Katsutoshi Tokushige
Journal:  Gastroenterol Res Pract       Date:  2016-06-16       Impact factor: 2.260

5.  Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease.

Authors:  Hong-Hui Wang; Ying He; Hong-Xian Wang; Cheng-Ling Liao; Yu Peng; Li-Jian Tao; Wei Zhang; Hui-Xiang Yang
Journal:  World J Gastroenterol       Date:  2018-02-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.